Inositol in preterm infants at risk for or having respiratory distress syndrome

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Howlett, Alexandra ^a,b   Ohlsson, Arne ^c   Plakkal, Nishad ^d  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; PLACEBO; VITAMIN B COMPLEX;

BRAIN HEMORRHAGE; CHILD DEATH; CLINICAL EFFECTIVENESS; DEVELOPMENTAL DISORDER; DRUG SAFETY; FETUS OUTCOME; HEARING TEST; HOSPITALIZATION; HUMAN; INFANT MORTALITY; LEUKOMALACIA; LUNG DYSPLASIA; MORTALITY RATE; NECROTIZING ENTEROCOLITIS; NEWBORN DEATH; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SEPSIS; SIDE EFFECT; SYSTEMATIC REVIEW; DIET SUPPLEMENTATION; META ANALYSIS; MORTALITY; NEWBORN; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

DIETARY SUPPLEMENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INOSITOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; VITAMIN B COMPLEX;

EID: 84934301455     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000366.pub3     Document Type: Review

References (33)

1. Friedman CA, McVey J, Borne MJ, James M, May WL, Temple DM. Relationship between serum inositol concentration and development of retinopathy of prematurity: A prospective study. Journal of Pediatric Ophthalmoly and Strabismus 2000;37(2):79-86. [PUBMED: 10779265]
2. Friedman CA, Temple DM, Robbins KK, Miller CJ, Rawson JE. Randomized controlled trial of high inositol and calorie supplementation in preterm infants at risk for chronic lung and eye disease. American Academy of Pediatrics Annual Meeting; San Francisco, California, USA. 1995 October.
3. Hallman M, Jarvanpaa AL, Pohjavuori M. Respiratory distress syndrome and inositol supplementation in preterm infants. Archives of Disease in Childhood 1986;61(11):1076-83. [PUBMED: 3539028]
4. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M. Inositol supplementation in premature infants with respiratory distress syndrome. New England Journal of Medicine 1992;326(19):1233-9. [PUBMED: 1560798]
5. Hallman M, Pohjavuori M, Bry K. Inositol supplementation in respiratory distress syndrome. Lung 1990;168 Suppl:877-82. [PUBMED: 2117207]
6. Phelps D, Ward R, Kerns S, on behalf of the Inositol Subcommittee of the Neonatal Research Network. Pharmacokinetics and safety of a single dose of inositol in preterm infants. E-PAS2010. 2010:3737.387.
7. Phelps DL, Ward RM, Williams RL, Watterberg KL, Laptook AR, Wrage LA, et al.Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk. Pediatric Research 2013;74(6):721-9. [PUBMED: 24067395 ]
8. Phelps D, Watterberg K, Nolen T, Ward R, for the Inositol Subcommittee. Inositol serum concentrations and safety in a daily dose ranging study for extremely preterm infants. E-PAS2012. 2012:1536.654.
9. NCT01954082 . Inositol to reduce retinopathy of prematurity (INS-3). clinicaltrials.gov/ct2/show/NCT01954082 (accessed on 30 April 2014).
10. Bell MJ, Ternberg KL, Feigin RD, Keating JP, Marshall R, Barton L, et al.Neonatal necrotising enterocolitis: therapeutic decisions based on clinical staging. Annals of Surgery 1978;187(1):1-7. [PUBMED: 413500]
11. Bromberger P, Hallman M. Myoinositol in small preterm infants: Relationship between intake and serum concentration. Journal of Pediatric Gastroenterology and Nutrition 1986;5(3):455-8. [PUBMED: 3088251]
12. Burton LE, Wells WW. Studies on the development pattern of the enzymes converting glucose-6-phosphate to myo-inositol in the rat. Developmental Biology 1974;37(1):35-42. [PUBMED: 4362962]
13. Dawson RM, Freinkel N. The distribution of free mesoinositol in mammalian tissues, including some observations on the lactating rat. The Biochemical Journal 1961;78:606-10. [PUBMED: 13720328]
14. Eagle H, Oyama VI, Levy M, Freeman AE. Myo-inositol as an essential growth factor for normal and malignant human cells in tissue culture. The Journal of Biological Chemistry 1957;266(1):191-205. [PUBMED: 13428752]
15. Egberts J, Noort WA. Gestational age-dependent changes in plasma inositol levels and surfactant composition in the fetal rat. Pediatric Research 1986;20(1):24-7. [PUBMED: 3753753]
16. Guarner V, Tordet C, Bourbon JR. Effects of maternal protein-calorie malnutrition on the phospholipid composition of surfactant isolated from the fetal and neonatal rat lungs. Compensation by inositol and lipid supplementation. Pediatric Research 1992;31(6):629-35. [PUBMED: 1635827]
17. Hallman M, Epstein BL. Role of myo-inositol in the synthesis of phosphatidylglycerol and phosphatidylinositol in the lung. Biochemical and Biophysical Research Communications 1980;92(4):1151-9. [PUBMED: 6245646]
18. Hallman M. Effect of intracellular myo-inositol on the surfactant phospholipid synthesis in the fetal rabbit lung. Biochimica et Biophysica Acta 1984;795(1):67-78.
19. Hallman M, Saugstad OD, Porreco RP, Epstein BL, Gluck L. Role of myo-inositol in regulation of surfactant phospholipids in the newborn. Early Human Devevelopment 1985;10(3-4):245-54. [PUBMED: 3838720]
20. Hallman M, Arjomaa P, Hoppu K. Inositol supplementation in respiratory distress syndrome: Relationship between serum concentration, renal excretion, and lung effluent phospholipids. Journal of Pediatrics 1987;110(4):604-10. [PUBMED: 3559811]
21. Hasan SH, Nishigaki I, Tsutsui Y, Yagi K. Studies on myoinositol IX. Morphological examination of the effect of massive doses of myoinositol on the liver and kidney of rat. Journal of Nutritional Science and Vitaminology 1974;20(1):55-8. [PUBMED: 4836951]
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [PUBMED: 12958120]
23. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Archives of Ophthalmology 1984;102(8):1130-4. [PUBMED: 6547831]
25. Lewin LM, Melmed S, Passwell JH, Yannai Y, Brish M, Orda S, et al.Myoinositol in human neonates: serum concentrations and renal handling. Pediatric Research 1978;12(1):3-6. [PUBMED: 643373]
26. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1, 500 grams. Journal of Pediatrics 1978;92(4):529-34. [PUBMED: 305471]
27. Pereira GR, Baker L, Egler J, Corcoran L, Chiavacci R. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. American Journal of Clinical Nutrition 1990;51(4):589-93. [PUBMED: 2108579]
28. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
29. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82(4):527-32. [PUBMED: 3174313]
30. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992.
31. Howlett A, Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 1997, Issue 4. [DOI: 10.1002/14651858.CD000366]
32. Howlett A, Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD000366]
33. Howlett A, Ohlsson A, Plakkal N. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD000366.pub2]